This guideline responds to requests from organizations, institutions and individuals for guidance which consolidates existing recommendations specific to women living with HIV along with new recommendations and good practice statements. It is expected to support front-line health-care providers, programme managers and public health policy-makers around ...

This document presents new WHO recommendations and guidance on: 1. HIV self-testing 2. Partner notification To achieve the United Nations (UN) 90–90–90 global HIV targets – and specifically the first target of diagnosing 90% of all people with HIV – the World Health Organization (WHO) released the Consolidated ...

Health systems and services depend critically on the size, skills and commitment of the health workforce. It is now evident that in many low- and middle-income countries, meeting key Millennium Development Goal targets, specifically those relating to health, requires a significant increase in the numbers ...

The Guide to Monitoring and Evaluation of Advocacy, Communication, and Social Mobilization to Support Tuberculosis Prevention and Care was developed in response to this increased demand for broad-scope M&E of ACSM activities. While rigorous evaluation provides the best evidence to support scale-up of specific ACSM ...

First generation surveillance relied solely on data on AIDS cases and some sentinel studies on HIV prevalence. In 2000, a new strategy named second generation surveillance (SGS) was promoted to tailor surveillance systems to the epidemic state of a country (1). More specifically, the strategy ...

People living with the human immunodeficiency virus (HIV) are 29 times (26-31) more likely to develop tuberculosis (TB) disease as people without HIV and living in the same country. TB is a leading cause of death among people living with HIV, accounting for one in ...

With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...

HIV testing is the gateway to HIV prevention, treatment, care and other support services. The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organisation (WHO) have endorsed global goals to achieve “zero new HIV infections, zero discrimination and zero AIDS-related deaths” by ...

Forging a Path to 90-90-90: Launch of WHO Guidelines on HIV Testing Services and UNAIDS/WHO Guidelines on Conducting National Population-based HIV Surveys

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

Recommendations for the selection and use of HIV antibody tests were first issued by WHO in 1992.1 Since then the range of HIV antibody tests available has expanded. New types of assays have been developed and the overall quality has improved. HIV tests for other ...

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national HIV testing strategies or programmes in the countries of the European Union (EU) and the European Economic Area (EEA). It is intended to complement the following existing guidance: Scaling up HIV testing ...

These guidelines aim to: provide comprehensive evidence-based recommendations for HTS; support testing by trained lay providers to increase access to HTS through communitybased approaches; offer guidance to countries to deliver a mix of HTS approaches appropriate to their epidemic context, focusing on HTS for groups ...